Sickle Cell Disease Treatment Centers Act of 2026

Cost and committee reports

Official records Congress.gov attaches to H.R. 10531.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Ms. ADAMS, as printed in the Congressional Record (Vol. 172, No. 152, September 24, 2026, Page H6004):
  Clause 18 of Section 8 of Article 1 of the Constitution
  Source: Congress.gov, Congressional Record September 24, 2026 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  55 characters

  Congress.gov bill record

  H.R. 10531, 119th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/119/hr/10531

  Record last updated by Congress.gov

  October 14, 2026

  PORKER copy retrieved

  October 19, 2026

  Stored copy, SHA-256 of the file

  cacd74343bc2c5f9bd9052bb31a65575e911de54eaed8ed771e026ba70363632

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of October 14, 2026). Not every bill gets one.

From the Congress.gov bill record for H.R. 10531, last updated October 14, 2026. PORKER’s copy was retrieved October 19, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.